Sartorius Presents Annual Report for 2021

January 20, 2022 – Pharmaceutical


The life science group Sartorius today has presented its 2021 Annual Report. Besides providing detailed information on its business performance, as well as on innovations, acquisitions and sustainability initiatives, the company also confirms its preliminary figures for fiscal 2021, which had already been published on January 27, 2022.

The companyís outlook for fiscal 2022, updated on February 8, was also confirmed. Accordingly, Group sales revenue is expected to increase by about 15 percent to 19 percent. This includes an expected non-organic growth contribution from acquisitions of about 2 percentage points. The companyís underlying EBITDA margin is forecasted to reach about 34 percent. All figures for the forecast are based on constant currencies.

Sartorius Corporation, Otto-Brenner-Straße 20, 37079 Goettingen, Germany